Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
310.00
0.00 (0.00%)
Jul 16, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $8.1 billion as of July 17, 2026. Its market cap has increased by 21.59% in one year.
Market Cap
8.10B
Enterprise Value
7.91B
1-Year Change
21.59%
Ranking
Category
Stock Price
$310.00
ChartMarket Cap Chart
Since July 19, 2021, Bio-Rad Laboratories's market cap has decreased from $20.09B to $8.10B, a decrease of -59.70%. That is a compound annual growth rate of -16.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 8.11B | -0.66% |
| Dec 31, 2025 | 8.17B | -11.01% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 12.57% |
| Jul 19, 2021 | 20.09B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zimmer Biomet Holdings | 17.44B |
| Smith & Nephew | 13.07B |
| Penumbra | 12.46B |
| Insulet | 11.03B |
| Globus Medical | 10.66B |
| Glaukos | 9.21B |
| Bruker | 8.93B |
| Bio-Rad Laboratories | 7.91B |